A Radiomics-Clinical Model Predicts Overall Survival of Non-Small Cell Lung Cancer Patients Treated with Immunotherapy: A Multicenter Study

A Radiomics-Clinical Model Predicts Overall Survival of Non-Small Cell Lung Cancer Patients Treated with Immunotherapy: A Multicenter Study

Background: Immune checkpoint inhibitors (ICIs) are a great breakthrough in cancer treatments and provide improved long-term survival in a subset of non-small cell lung cancer (NSCLC) patients. However, prognostic and predictive biomarkers of immunotherapy still remain an unmet clinical need. In thi...

Full description

Bibliographic Details
Main Authors: Sevinj Yolchuyeva, Elena Giacomazzi, Marion Tonneau, Leyla Ebrahimpour, Fabien C. Lamaze, Michele Orain, François Coulombe, Julie Malo, Wiam Belkaid, Bertrand Routy, Philippe Joubert, Venkata S. K. Manem
Format: Article
Language:English
Published: MDPI AG 2023-07-01
Series:Cancers
Subjects:
immunotherapy
non-small cell lung cancer
machine learning
overall survival
radiomics
Online Access:https://www.mdpi.com/2072-6694/15/15/3829

Internet

https://www.mdpi.com/2072-6694/15/15/3829

Similar Items